TY - JOUR
T1 - Estrogen Receptor Alpha Signaling Is Responsible for the Female Sex Bias in the Loss of Tolerance and Immune Cell Activation Induced by the Lupus Susceptibility Locus Sle1b
AU - Graham, Jared H.
AU - Yoachim, Shayla D.
AU - Gould, Karen A.
N1 - Funding Information:
We thank Kimberly Bynoté and Alexis Page for performing some of the ELISAs. We gratefully acknowledge Victoria Smith, Samantha Wall, and Drs. Philip Hexley and Craig Semerad of the University of Nebraska Medical Center Flow Cytometry Research Facility, who contributed to the acquisition and analysis of flow cytometric data. The UNMC Flow Cytometry Research Facility is administrated through the Office of the Vice Chancellor for Research and supported by state funds from the Nebraska Research Initiative (NRI) and The Fred and Pamela Buffett Cancer Center’s National Cancer Institute Cancer Support Grant. Major instrumentation in this facility has been
Funding Information:
We thank Kimberly Bynoté and Alexis Page for performing some of the ELISAs. We gratefully acknowledge Victoria Smith, Samantha Wall, and Drs. Philip Hexley and Craig Semerad of the University of Nebraska Medical Center Flow Cytometry Research Facility, who contributed to the acquisition and analysis of flow cytometric data. The UNMC Flow Cytometry Research Facility is administrated through the Office of the Vice Chancellor for Research and supported by state funds from the Nebraska Research Initiative (NRI) and The Fred and Pamela Buffett Cancer Center’s National Cancer Institute Cancer Support Grant. Major instrumentation in this facility has been provided by the Office of the Vice Chancellor for Research, The University of Nebraska Foundation, the Nebraska Banker’s Fund, and by the NIH-NCRR Shared Instrument Program. We also thank the UNMC Tissue Science Facility for processing and embedding the fixed spleens that were used for immunohistochemical analysis of spontaneous germinal centers. The UNMC Tissue Science Facility is administrated through the UNMC Department of Pathology and Microbiology and supported, in part, by The Fred and Pamela Buffett Cancer Center’s National Cancer Institute Cancer Support Grant.
Funding Information:
This work was supported by grants R01AI075167 and R01AI075167-S1 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. This work was also supported by a University of Nebraska Medical Center institutional support grant.
Publisher Copyright:
© Copyright © 2020 Graham, Yoachim and Gould.
PY - 2020/11/10
Y1 - 2020/11/10
N2 - The dramatic female sex bias observed in human lupus is thought to be due, at least in part, to estrogens. Using mouse models, we have shown that estrogens, acting through estrogen receptor alpha (ERα) promote lupus development and contribute significantly to the female sex bias observed in this disease. C57Bl/6 (B6) mice carrying the lupus susceptibility locus Sle1 locus exhibit immune cell hyperactivation and loss of tolerance, and the action of Sle1 displays a strong female sex bias. Previously, we showed that disruption of ERα completely eliminates the female sex bias in the effects of Sle1. Here we report that ERα signaling selectively modulates the action of Sle1b, one of the three subloci that together constitute Sle1. We observed that disruption of ERα signaling attenuated T cell hyperactivation, formation of spontaneous germinal centers, loss of tolerance, and the development of anti-chromatin autoantibodies in B6.Sle1b female mice, but had no impact on these phenotypes in B6.Sle1b male mice. In fact, disruption of ERα completely abolished the female sex bias that is seen in each of these phenotypes in B6.Sle1b mice. Strikingly, Sle1b-induced B cell hyperactivation, a female sex-specific manifestation of Sle1b, was completely abrogated by disruption of ERα in B6.Sle1b females. Altogether, these results demonstrate that ERα signaling is responsible for the female sex bias in the actions of Sle1b, and is absolutely required for the female-specific B cell hyperactivation phenotype associated with this lupus susceptibility locus. By contrast, we found that ERα signaling had no impact on Sle1a, the other Sle1 sublocus that exerts effects that show a female sex bias.
AB - The dramatic female sex bias observed in human lupus is thought to be due, at least in part, to estrogens. Using mouse models, we have shown that estrogens, acting through estrogen receptor alpha (ERα) promote lupus development and contribute significantly to the female sex bias observed in this disease. C57Bl/6 (B6) mice carrying the lupus susceptibility locus Sle1 locus exhibit immune cell hyperactivation and loss of tolerance, and the action of Sle1 displays a strong female sex bias. Previously, we showed that disruption of ERα completely eliminates the female sex bias in the effects of Sle1. Here we report that ERα signaling selectively modulates the action of Sle1b, one of the three subloci that together constitute Sle1. We observed that disruption of ERα signaling attenuated T cell hyperactivation, formation of spontaneous germinal centers, loss of tolerance, and the development of anti-chromatin autoantibodies in B6.Sle1b female mice, but had no impact on these phenotypes in B6.Sle1b male mice. In fact, disruption of ERα completely abolished the female sex bias that is seen in each of these phenotypes in B6.Sle1b mice. Strikingly, Sle1b-induced B cell hyperactivation, a female sex-specific manifestation of Sle1b, was completely abrogated by disruption of ERα in B6.Sle1b females. Altogether, these results demonstrate that ERα signaling is responsible for the female sex bias in the actions of Sle1b, and is absolutely required for the female-specific B cell hyperactivation phenotype associated with this lupus susceptibility locus. By contrast, we found that ERα signaling had no impact on Sle1a, the other Sle1 sublocus that exerts effects that show a female sex bias.
KW - B cell activation
KW - T cell activation
KW - estrogen receptor
KW - female
KW - immune tolerance
KW - lupus
KW - sex bias
UR - http://www.scopus.com/inward/record.url?scp=85096701954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096701954&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2020.582214
DO - 10.3389/fimmu.2020.582214
M3 - Article
C2 - 33240270
AN - SCOPUS:85096701954
SN - 1664-3224
VL - 11
JO - Frontiers in immunology
JF - Frontiers in immunology
M1 - 582214
ER -